thiazoles has been researched along with 1-methyl-4-phenylpyridinium in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (16.00) | 18.2507 |
2000's | 16 (64.00) | 29.6817 |
2010's | 5 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boireau, A; Doble, A; Dubédat, P; Meunier, M; Miquet, JM | 1 |
Kitamura, Y; Kohno, Y; Nakazawa, M; Nomura, Y | 1 |
Bennett, JP; Cassarino, DS; Fall, CP; Smith, TS | 1 |
Kakimura, JI; Kitamura, Y; Kohno, Y; Kosaka, T; Matsuoka, Y; Nomura, Y; Taniguchi, T | 1 |
Abramova, NN; Bennett, JP; Cassarino, DS; Halvorsen, EM; Parker, WD; Sturgill, TW; Swerdlow, RH | 1 |
Ferger, B; Teismann, P | 1 |
Kakimura, J; Kitamura, Y; Kohno, Y; Nomura, Y; Takata, K; Taniguchi, T | 1 |
Abramova, NA; Bennett, JP; Cassarino, DS; Khan, SM; Painter, TW | 1 |
Borwege, S; Hagner, D; Joyce, JN; Millan, MJ; Osredkar, T; PazSoldan, M; Presgraves, S; Renish, L; Replogle, M | 1 |
Jang, MH; Kim, CJ; Kim, EH; Shin, MC; Shin, MS | 1 |
Lin, LF; Rubin, LL; Xu, M | 1 |
Borwege, S; Joyce, JN; Millan, MJ; Presgraves, SP | 1 |
Cooper, JM; Gu, M; Iravani, MM; Irvani, M; Jenner, P; King, D; Schapira, AH | 1 |
Hillard, CJ; Joseph, J; Kalyanaraman, B; Shang, T | 1 |
Barkats, M; Colin, P; Faucon-Biguet, N; Horellou, P; Mallet, J; Millecamps, S | 1 |
Duka, T; Sidhu, A | 1 |
Ali, HK; Ali, SF; Binienda, ZK; Duhart, HM; Fu, X; Patterson, TA; Paule, MG; Sadovova, N; Slikker, W; Virmani, A; Wang, C; Zou, X | 1 |
Liu, RG; Shang, Y; Sun, SG; Wu, Y; Yang, WQ | 1 |
Abe, K; Horiguchi, Y; Kitabatake, M; Ogawa, K; Saitoh, T; Taguchi, K; Yamashita, A | 1 |
Chuang, JI; Hong, YT; Huang, JY | 1 |
Chen, VT; Huang, CL; Huang, NK; Lee, YC; Liao, WC | 1 |
Kim, LW; Kim, YH; Lee, BJ; Lee, CH; Lee, JG; Park, SW; Shin, BS | 1 |
Chien, WL; Fu, WM; Hung, SY; Kang, KH; Lee, MJ; Lee, TR | 1 |
Lew, J; Liu, W; Szumlinski, KK; Zhang, L | 1 |
Lu, BX; Luo, YF; Man, RY; Wang, XF; Zeng, QG; Zeng, Y | 1 |
25 other study(ies) available for thiazoles and 1-methyl-4-phenylpyridinium
Article | Year |
---|---|
Riluzole and experimental parkinsonism: partial antagonism of MPP(+)-induced increase in striatal extracellular dopamine in rats in vivo.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Excitatory Amino Acid Antagonists; Extracellular Space; Homovanillic Acid; Male; Parkinson Disease, Secondary; Rats; Riluzole; Thiazoles | 1994 |
Inhibitory effects of talipexole and pramipexole on MPTP-induced dopamine reduction in the striatum of C57BL/6N mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Azepines; Benzothiazoles; Bromocriptine; Dopamine; Dopamine Agents; Dopamine Agonists; Homovanillic Acid; In Vitro Techniques; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Neostriatum; Pramipexole; Synaptosomes; Thiazoles | 1997 |
Pramipexole reduces reactive oxygen species production in vivo and in vitro and inhibits the mitochondrial permeability transition produced by the parkinsonian neurotoxin methylpyridinium ion.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Antiparkinson Agents; Benzothiazoles; Biological Transport; Calcium; Corpus Striatum; Dopamine Agents; Humans; Ion Channel Gating; Liver; Male; Microdialysis; Mitochondria; Neuroblastoma; Neuroprotective Agents; Neurotoxins; Parkinson Disease, Secondary; Phosphorus; Porins; Pramipexole; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Thiazoles; Tumor Cells, Cultured | 1998 |
Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells.
Topics: 1-Methyl-4-phenylpyridinium; Antiparkinson Agents; Apoptosis; Azepines; Benzothiazoles; Bromocriptine; Bucladesine; Caspase 3; Caspases; Dopamine Agonists; Humans; Pramipexole; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Thiazoles; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1998 |
Interaction among mitochondria, mitogen-activated protein kinases, and nuclear factor-kappaB in cellular models of Parkinson's disease.
Topics: 1-Methyl-4-phenylpyridinium; Adenine Nucleotides; Benzothiazoles; Electron Transport; Enzyme Activation; Free Radical Scavengers; Herbicides; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase Kinase 1; Mitochondria; Mitogen-Activated Protein Kinases; Neuroblastoma; Neurons; NF-kappa B; Oxidative Stress; Parkinson Disease; Peptides; Pramipexole; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-raf; Signal Transduction; Superoxide Dismutase; Thiazoles; Tumor Cells, Cultured | 2000 |
Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Count; Cyclooxygenase 1; Cyclooxygenase 2; Disease Models, Animal; Dopamine; Homovanillic Acid; Isoenzymes; Male; Meloxicam; Membrane Proteins; Mice; Mice, Inbred C57BL; Motor Activity; Neostriatum; Neuroprotective Agents; Parkinsonian Disorders; Prostaglandin-Endoperoxide Synthases; Substantia Nigra; Thiazines; Thiazoles; Tyrosine 3-Monooxygenase | 2001 |
Release and aggregation of cytochrome c and alpha-synuclein are inhibited by the antiparkinsonian drugs, talipexole and pramipexole.
Topics: 1-Methyl-4-phenylpyridinium; alpha-Synuclein; Antiparkinson Agents; Azepines; Benzothiazoles; Caspases; Cell-Free System; Cytochrome c Group; Cytosol; Deoxyadenine Nucleotides; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Nerve Tissue Proteins; Organelles; Pramipexole; Synucleins; Thiazoles; Tumor Cells, Cultured | 2001 |
Inhibition by R(+) or S(-) pramipexole of caspase activation and cell death induced by methylpyridinium ion or beta amyloid peptide in SH-SY5Y neuroblastoma.
Topics: 1-Methyl-4-phenylpyridinium; Alzheimer Disease; Amyloid beta-Peptides; Anti-Bacterial Agents; Aristolochic Acids; Benzothiazoles; Bongkrekic Acid; Brain; Caspase Inhibitors; Caspases; Cell Death; Dose-Response Relationship, Drug; Enzyme Inhibitors; Free Radical Scavengers; Humans; Neuroblastoma; Neurodegenerative Diseases; Neurons; Parkinson Disease; Peptide Fragments; Phenanthrenes; Pramipexole; Thiazoles; Tumor Cells, Cultured | 2002 |
Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Antiparkinson Agents; Benzothiazoles; Cell Count; Cell Line; DNA; Dopamine Agents; Dopamine Agonists; Humans; Immunohistochemistry; Indoles; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Oxazines; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Tetrazolium Salts; Thiazoles | 2003 |
Protective effect of aqueous extract of Ginseng radix against 1-methyl-4-phenylpyridinium-induced apoptosis in PC12 cells.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Caspase 3; Caspase Inhibitors; Caspases; Cell Cycle; Cell Shape; Cell Survival; DNA Fragmentation; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Genes, p53; Neurons; Panax; PC12 Cells; Plant Extracts; Plant Roots; Plants, Medicinal; Proto-Oncogene Proteins c-bcl-2; Rats; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Suppressor Protein p53; Water | 2003 |
A non-peptidyl neurotrophic small molecule for midbrain dopaminergic neurons.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Apoptosis; Astrocytes; Cell Count; Cell Survival; Cells, Cultured; Colforsin; Dopamine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Glial Cell Line-Derived Neurotrophic Factor; Mesencephalon; Nerve Growth Factors; Neurons; Neuroprotective Agents; Neurotoxins; Rats; Sensitivity and Specificity; Serotonin; Sulfonamides; Thiazoles; Tyrosine 3-Monooxygenase | 2004 |
Involvement of dopamine D(2)/D(3) receptors and BDNF in the neuroprotective effects of S32504 and pramipexole against 1-methyl-4-phenylpyridinium in terminally differentiated SH-SY5Y cells.
Topics: 1-Methyl-4-phenylpyridinium; Antibodies; Benzothiazoles; Brain-Derived Neurotrophic Factor; Cell Differentiation; Cell Line; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Enzyme Inhibitors; Humans; Neuroblastoma; Neurons; Neuroprotective Agents; Oxazines; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Tetradecanoylphorbol Acetate; Thiazoles; Tretinoin | 2004 |
Pramipexole protects against apoptotic cell death by non-dopaminergic mechanisms.
Topics: 1-Methyl-4-phenylpyridinium; Aconitate Hydratase; Antioxidants; Benzothiazoles; Carbocyanines; Caspase 3; Caspases; Cell Count; Cell Death; Cell Line, Tumor; Cell Survival; Cytochromes c; Dose-Response Relationship, Drug; Drug Interactions; Flow Cytometry; Humans; Jurkat Cells; L-Lactate Dehydrogenase; Mitochondria; Necrosis; Neuroblastoma; Pramipexole; Rotenone; Thiazoles | 2004 |
Death-associated protein kinase as a sensor of mitochondrial membrane potential: role of lysosome in mitochondrial toxin-induced cell death.
Topics: 1-Methyl-4-phenylpyridinium; Aconitate Hydratase; Antimycin A; Antioxidants; Apoptosis Regulatory Proteins; Calcium-Calmodulin-Dependent Protein Kinases; Cell Death; Cell Line, Tumor; Death-Associated Protein Kinases; Electron Transport; Humans; Lysosomes; Membrane Potentials; Microscopy, Electron; Mitochondrial Membranes; Models, Biological; Phosphatidylinositol 3-Kinases; Phosphorylation; Rotenone; Subcellular Fractions; Tetrazolium Salts; Thiazoles; Time Factors; Toxins, Biological | 2005 |
1-methyl-4-phenylpyridinium neurotoxicity is attenuated by adenoviral gene transfer of human Cu/Zn superoxide dismutase.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Cell Count; Cell Line, Tumor; Disease Models, Animal; Female; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Humans; Immunohistochemistry; Motor Activity; Neuroblastoma; Neurotoxicity Syndromes; Parkinson Disease; Rats; Rotarod Performance Test; Substantia Nigra; Superoxide Dismutase; Tetrazolium Salts; Thiazoles; Transgenes; Tyrosine 3-Monooxygenase | 2006 |
The neurotoxin, MPP+, induces hyperphosphorylation of Tau, in the presence of alpha-Synuclein, in SH-SY5Y neuroblastoma cells.
Topics: 1-Methyl-4-phenylpyridinium; alpha-Synuclein; Blotting, Western; Cell Fractionation; Cell Line, Tumor; Cell Survival; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Gene Expression; Humans; Neuroblastoma; Neurotoxins; Phosphorylation; Serine; tau Proteins; Tetrazolium Salts; Thiazoles; Transfection | 2006 |
L-carnitine protects neurons from 1-methyl-4-phenylpyridinium-induced neuronal apoptosis in rat forebrain culture.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Blotting, Western; Carnitine; Cell Nucleus; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; In Situ Nick-End Labeling; L-Lactate Dehydrogenase; Neurons; Neuroprotective Agents; Prosencephalon; Rats; Rats, Sprague-Dawley; Sialic Acids; Tetrazolium Salts; Thiazoles | 2007 |
Protective effect of erythropoietin against 1-methyl-4-phenylpyridinium-induced neurodegenaration in PC12 cells.
Topics: 1-Methyl-4-phenylpyridinium; Analysis of Variance; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Survival; Dose-Response Relationship, Drug; Drug Interactions; Erythropoietin; Flow Cytometry; Herbicides; In Situ Nick-End Labeling; Membrane Potential, Mitochondrial; Neuroprotective Agents; PC12 Cells; Proto-Oncogene Proteins c-bcl-2; Rats; Reactive Oxygen Species; Tetrazolium Salts; Thiazoles | 2007 |
Synthesis of chiral 3-methyl- and 3-methyl-N-propargyl-1,2,3,4-tetrahydroisoquinoline and prevention of MPP+ -induced cytotoxicity.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Cell Death; Data Interpretation, Statistical; Dopamine Agents; Dopamine Antagonists; Models, Molecular; PC12 Cells; Rats; Stereoisomerism; Structure-Activity Relationship; Tetrahydroisoquinolines; Tetrazolium Salts; Thiazoles | 2008 |
Fibroblast growth factor 9 prevents MPP+-induced death of dopaminergic neurons and is involved in melatonin neuroprotection in vivo and in vitro.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Animals, Newborn; Antibodies; Cell Death; Dopamine; Dose-Response Relationship, Drug; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Fibroblast Growth Factor 9; Fibroblast Growth Factors; Glial Fibrillary Acidic Protein; Herbicides; Male; Melatonin; Mesencephalon; Microtubule-Associated Proteins; Neurons; Neuroprotective Agents; Rats; Rats, Wistar; Tetrazolium Salts; Thiazoles; Time Factors; Tyrosine 3-Monooxygenase | 2009 |
The roles of the thioredoxin system and peroxiredoxins in 1-methyl-4-phenyl-pyridinium ion-induced cytotoxicity in rat pheochromocytoma cells.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Antineoplastic Agents; Apoptosis; Cell Survival; Lipid Peroxidation; Membrane Potential, Mitochondrial; Oxidation-Reduction; PC12 Cells; Peroxiredoxins; Pheochromocytoma; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Rats; Reactive Oxygen Species; Superoxides; Tetrazolium Salts; Thiazoles; Thioredoxins; Tumor Stem Cell Assay | 2010 |
Protective effects of atypical antipsychotic drugs against MPP(+)-induced oxidative stress in PC12 cells.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Antipsychotic Agents; Aripiprazole; bcl-2-Associated X Protein; Benzodiazepines; Blotting, Western; Cell Survival; Haloperidol; Herbicides; Olanzapine; Oxidative Stress; PC12 Cells; Piperazines; Quinolones; Rats; Reactive Oxygen Species; Superoxide Dismutase; Thiazoles | 2011 |
Impairment of oxidative stress-induced heme oxygenase-1 expression by the defect of Parkinson-related gene of PINK1.
Topics: 1-Methyl-4-phenylpyridinium; Adenoviridae; Benzimidazoles; Blotting, Western; Cell Line; Cell Survival; Cloning, Molecular; Coloring Agents; Dopamine; Fluorescent Antibody Technique; Fluorescent Dyes; Gene Expression Regulation; Genetic Vectors; Heme Oxygenase-1; HSP90 Heat-Shock Proteins; Humans; L-Lactate Dehydrogenase; Mutation; Oxidative Stress; Parkinson Disease, Secondary; Protein Kinases; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA; Tetrazolium Salts; Thiazoles | 2011 |
p10, the N-terminal domain of p35, protects against CDK5/p25-induced neurotoxicity.
Topics: 1-Methyl-4-phenylpyridinium; Adaptor Proteins, Signal Transducing; Animals; Blotting, Western; Cell Cycle Proteins; Cell Survival; Chlorocebus aethiops; Chromobox Protein Homolog 5; COS Cells; Cyclin-Dependent Kinase 5; Immunohistochemistry; Microscopy, Fluorescence; Nerve Tissue Proteins; Neurons; Peptide Fragments; Peptides; Peroxiredoxins; Phosphorylation; Proteolysis; Rats; Reactive Oxygen Species; Tetrazolium Salts; Thiazoles | 2012 |
Induction of GADD45α protects M17 neuroblastoma cells against MPP*.
Topics: 1-Methyl-4-phenylpyridinium; Analysis of Variance; Anthracenes; Blotting, Western; Caspase 3; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Chromatin Immunoprecipitation; Dose-Response Relationship, Drug; Gene Expression Regulation; Humans; Imidazoles; In Situ Nick-End Labeling; Nuclear Proteins; Parkinson Disease; Pyridines; Real-Time Polymerase Chain Reaction; RNA Interference; Tetrazolium Salts; Thiazoles | 2014 |